ArticleJournal of cardiovascular imaging2026
Left ventricular stroke volume index predicts outcomes in asymptomatic chronic severe primary mitral regurgitation.
Article in Journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSevere primary mitral regurgitation (MR) linked to substantial morbidity and mortality. However, racial differences impact the left ventricular size, which subsequently influence specific echocardiographic parameters. In this context, the left ventricular stroke volume index (LVSVi) may serve as a valuable prognostic indicator. This study aims to examine the association between LVSVi and a composite endpoint of all-cause mortality or mitral valve (MV) surgery.
methodsWe conducted a retrospective study on asymptomatic chronic severe primary MR patients over a 5-year follow-up period.
resultsAmong 77 patients with asymptomatic severe primary MR (mean age, 56.9 years; 55 male patients, 71.4%), an increase of 1 mL/m
conclusionsIn patients with asymptomatic chronic severe primary MR, LVSVi was the significant echocardiographic parameter influencing the outcomes of MV surgery and mortality. This study supported the hypothesis generation that LVSVi may serve as a prognostic marker in this specific population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.